During a Case-Based Roundtable® event, Ticiana Leal, MD, discusses phase 3 trials of combinations in the non–small cell lung ...

SAN ANTONIO, October 18, 2024--bioAffinity Technologies announces pricing of $2.66 million registered direct offering and ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

A ChatGPT-like model can diagnose cancer, assist in selecting treatment options, and predict survival outcomes across various ...

Efforts to bring higher quality care to Johnson County residents have led to local health systems teaming up with national ...

Its benefits are reported to be many, from reducing the risk of developing Alzheimer's to improving oral health and keeping ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study.

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective ...

An "out-of-this-world" project has the potential to transform the future of tissue engineering and liver transplantation ...

The global tissue diagnostics market was valued at US$4.2 billion in the year 2020 and is forecast to be worth US$8.3 billion by the year 2030. The market anticipates growing at a compound annual ...

Catherine, Princess of Wales, was diagnosed with cancer earlier this year. She's since undergone treatment and is now considered cancer free. After revealing she had completed her chemotherapy ...